WPD-102

N/A

Report date: 2024/11/08 11:13:17

Base Information

Drug NameWPD-102
Drug Alias NameWPD-102
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-13 receptor subunit alpha-2 modulators
TargetsInterleukin-13 receptor subunit alpha-2
Therapy Area/IndicationsUveal melanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWPD Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesWPD Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsUveal melanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A